FDA Guidance on Medicine Counterfeit Protection: The Critical Role of Secure Authentication in Drug Delivery and Device Security White Paper


In December 2023, the U.S. Food and Drug Administration (FDA) issued the final guidance for “Verification Systems Under the Drug Supply Chain Security Act for Certain Prescription Drugs”. Embedded electronic system architects play a critical role in the design of medical products that dispense liquid, gas, or gel-based medicines. These devices must not only ensure precise and reliable delivery of treatments but also comply with stringent FDA guidance designed to protect patients against counterfeit or adulterated drugs.

This dual challenge elevates system design beyond traditional embedded development, requiring secure hardware architectures, cryptographic authentication, and trusted supply chain provisioning. By embedding security at the core of the dispensing electronics, architects can help ensure that every administered dose is both accurate and authentic—protecting patients, meeting regulatory requirements, and strengthening trust in next-generation medical devices.

Don't miss out on this invaluable resource. Download your free copy of the white paper and gain a competitive edge in the rapidly evolving world of security.

Download Now

By submitting this form, I agree to Microchip's Terms and Conditions and Privacy Policy.